DE602005016392D1 - Verwendung von loteprednoletabonat zur behanldung von trockenen augen - Google Patents

Verwendung von loteprednoletabonat zur behanldung von trockenen augen

Info

Publication number
DE602005016392D1
DE602005016392D1 DE602005016392T DE602005016392T DE602005016392D1 DE 602005016392 D1 DE602005016392 D1 DE 602005016392D1 DE 602005016392 T DE602005016392 T DE 602005016392T DE 602005016392 T DE602005016392 T DE 602005016392T DE 602005016392 D1 DE602005016392 D1 DE 602005016392D1
Authority
DE
Germany
Prior art keywords
loteprednoletabonate
treatment
dry eyes
patient
ophthalmolically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005016392T
Other languages
English (en)
Inventor
Stephen P Bartels
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch and Lomb Inc
Original Assignee
Bausch and Lomb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34963566&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602005016392(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bausch and Lomb Inc filed Critical Bausch and Lomb Inc
Publication of DE602005016392D1 publication Critical patent/DE602005016392D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
DE602005016392T 2004-03-25 2005-03-24 Verwendung von loteprednoletabonat zur behanldung von trockenen augen Active DE602005016392D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55616104P 2004-03-25 2004-03-25
PCT/US2005/009761 WO2005094836A2 (en) 2004-03-25 2005-03-24 Use of loteprednol etabonate for the treatment of dry eye

Publications (1)

Publication Number Publication Date
DE602005016392D1 true DE602005016392D1 (de) 2009-10-15

Family

ID=34963566

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005016392T Active DE602005016392D1 (de) 2004-03-25 2005-03-24 Verwendung von loteprednoletabonat zur behanldung von trockenen augen

Country Status (15)

Country Link
US (1) US20050222110A1 (de)
EP (2) EP1744759B1 (de)
JP (1) JP2007530573A (de)
KR (1) KR20070004750A (de)
CN (1) CN1964719B (de)
AT (1) ATE441419T1 (de)
AU (1) AU2005229006B9 (de)
BR (1) BRPI0509220A (de)
CA (1) CA2560824A1 (de)
DE (1) DE602005016392D1 (de)
ES (1) ES2330762T3 (de)
HK (1) HK1102551A1 (de)
MX (1) MXPA06010849A (de)
TW (1) TW200602030A (de)
WO (1) WO2005094836A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
CN101317847B (zh) * 2007-06-06 2010-10-13 深圳市瑞谷医药技术有限公司 一种眼用或耳鼻用药物组合物及其用途
US20090239836A1 (en) * 2008-03-24 2009-09-24 Mary Lee Ciolkowski Multifunctional Ophthalmic Compositions
US8835410B2 (en) 2011-05-10 2014-09-16 Bodor Laboratories, Inc. Treatment of eyelid dermatitis
WO2013133980A1 (en) * 2012-03-05 2013-09-12 Bausch & Lomb Incorporated Nitroxy derivatives of soft steroids
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US9056057B2 (en) 2012-05-03 2015-06-16 Kala Pharmaceuticals, Inc. Nanocrystals, compositions, and methods that aid particle transport in mucus
US10688041B2 (en) 2012-05-03 2020-06-23 Kala Pharmaceuticals, Inc. Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucus
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
WO2014127214A1 (en) 2013-02-15 2014-08-21 Kala Pharmaceuticals, Inc. Therapeutic compounds and uses thereof
EP2958895B1 (de) 2013-02-20 2020-08-19 Kala Pharmaceuticals, Inc. Therapeutische verbindungen und verwendungen davon
US9688688B2 (en) 2013-02-20 2017-06-27 Kala Pharmaceuticals, Inc. Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
US9890173B2 (en) 2013-11-01 2018-02-13 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
CN106061261B (zh) 2013-11-01 2018-04-24 卡拉制药公司 治疗化合物的结晶形式及其用途
CN106279324A (zh) * 2015-05-27 2017-01-04 天津金耀集团有限公司 依碳氯替泼诺一水合物及其晶型与制备方法
CN106279325A (zh) * 2015-05-27 2017-01-04 天津金耀集团有限公司 一种依碳氯替泼诺新晶型及其制备方法
CN106892952A (zh) * 2015-12-21 2017-06-27 天津金耀集团有限公司 一种依碳氯替泼诺新晶型及其制备方法
CN106892953A (zh) * 2015-12-21 2017-06-27 天津金耀集团有限公司 依碳氯替泼诺一水合物及其晶型与制备方法
EP3509423A4 (de) 2016-09-08 2020-05-13 Kala Pharmaceuticals, Inc. Kristalline formen von therapeutischen verbindungen und verwendungen davon
WO2018048747A1 (en) 2016-09-08 2018-03-15 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
MX2019002629A (es) 2016-09-08 2019-10-07 Kala Pharmaceuticals Inc Formas cristalinas de compuestos terapéuticos y usos de los mismos.
CN110996904A (zh) * 2017-05-19 2020-04-10 奥古根有限公司 眼用组合物及使用方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US104A (en) 1836-12-10 Revolving hokse-rake
US5075A (en) 1847-04-17 Improvement in cultivators
US4996335A (en) 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
US6610675B1 (en) 1980-07-10 2003-08-26 Nicholas S. Bodor Inactive metabolite approach to soft drug design
US4710495A (en) 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity
US4883658A (en) 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4804539A (en) 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
US5278151A (en) 1987-04-02 1994-01-11 Ocular Research Of Boston, Inc. Dry eye treatment solution
US4914088A (en) 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
ATE132366T1 (de) 1990-05-29 1996-01-15 Boston Ocular Res Zusammensetzung zur behandlung von dry eye erkrankungen
ZA912797B (en) 1990-05-29 1992-12-30 Boston Ocular Res Dry eye treatment process and solution
ZA927277B (en) 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
WO1997020578A1 (en) 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
US7073504B2 (en) * 1996-12-18 2006-07-11 Ams Research Corporation Contraceptive system and method of use
US6096052A (en) * 1998-07-08 2000-08-01 Ovion, Inc. Occluding device and method of use
TW503113B (en) 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액
DE19947234A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
US20030008853A1 (en) 2001-05-21 2003-01-09 Alcon, Inc. Method for treating dry eye disorders
KR20050030884A (ko) * 2001-10-11 2005-03-31 알콘, 인코퍼레이티드 항염증성 스테로이드 및 ｍｕｃ-1 분비촉진제 배합에 의한안구 건조증 치료 방법
BR0307893A (pt) * 2002-02-22 2004-12-07 Pharmacia Corp Formulação oftálmica com sistema de goma
US7074426B2 (en) * 2002-03-27 2006-07-11 Frank Kochinke Methods and drug delivery systems for the treatment of orofacial diseases
US20040151754A1 (en) * 2002-12-20 2004-08-05 Control Delivery Systems, Inc. Steroid suspensions for intraocular use
JP4430616B2 (ja) * 2003-02-20 2010-03-10 千寿製薬株式会社 水性懸濁液剤
US20050182039A1 (en) * 2004-02-13 2005-08-18 Bausch & Lomb Incorporated Use of Loteprednol etabonate for the treatment of dry eye

Also Published As

Publication number Publication date
US20050222110A1 (en) 2005-10-06
AU2005229006B9 (en) 2011-05-19
KR20070004750A (ko) 2007-01-09
CN1964719A (zh) 2007-05-16
TW200602030A (en) 2006-01-16
AU2005229006A1 (en) 2005-10-13
MXPA06010849A (es) 2007-03-08
ES2330762T3 (es) 2009-12-15
JP2007530573A (ja) 2007-11-01
WO2005094836A3 (en) 2006-01-26
CN1964719B (zh) 2010-05-05
EP1744759A2 (de) 2007-01-24
EP2127655A1 (de) 2009-12-02
HK1102551A1 (en) 2007-11-30
CA2560824A1 (en) 2005-10-13
AU2005229006B2 (en) 2011-01-20
WO2005094836A2 (en) 2005-10-13
ATE441419T1 (de) 2009-09-15
EP1744759B1 (de) 2009-09-02
BRPI0509220A (pt) 2007-09-04

Similar Documents

Publication Publication Date Title
DE602005016392D1 (de) Verwendung von loteprednoletabonat zur behanldung von trockenen augen
WO2005096981A3 (en) Method and apparatus for dermatological treatment
EA200801717A1 (ru) Композиция местного применения по уходу за кожей, продукт на ее основе и способ лечения
DE60312309D1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
ATE551996T1 (de) Behandlung oder prävention von diabetes mit cannabidiol
ATE509663T1 (de) Ballon-brachytherapie-applikator
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
DE60333605D1 (de) Tuberkulosebehandlung mit Pleuromutilinderivaten
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
ATE289816T1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
WO2003057162A3 (en) Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
CY1107562T1 (el) Χρηση των ν-(2-αρυλ-προπιονυλ)-σουκλφοναμιδιων για τη θepαπεια του τραυματος του νωτιαιου μυελου
ATE380554T1 (de) Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie
NO20063320L (no) Anvendelse av gaboxadol for behandling av insomni
WO2004045554A3 (en) Cytomodulating peptides for treating interstitial cystitis
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
DE60216292D1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
ATE367823T1 (de) E-selectin zur behandlung oder vorbeugung von schlaganfall
CN203710557U (zh) 脑血管病人康复用头部按摩器
CN204049964U (zh) 趾甲矫正器
RU2008128396A (ru) Способ оздоровления организма
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components
RU2009100338A (ru) Способ лечения гипербилирубинемии новорожденных
UA109076U (uk) Спосіб хірургічного лікування пошкодження сухожилля згинача пальця кисті
UA6397U (en) Method for treating patients with vibration disease by hyperbaric oxygenation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition